BioMarin Pharmaceuticals
BMRN
NASDAQ
IPO1999
about BMRN
BioMarin Pharmaceuticals develops life-saving therapies for rare diseases, including treatments like Vimizim for Gaucher disease.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $63.09 | $64.25 | $62.55 | $12.3B | 3.63M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.16 | n/a | n/a | -6.02% | -3.96% | 0% |